There were two related objectives in this study. The first was to determine the influence of endogenous relaxin on ovulation in rats. The second was to investigate the effect of relaxin on the secretion of gelatinases involved in extracellular matrix remodeling from rat ovarian cells.
INTRODUCTION
Relaxin, a peptide hormone of pregnancy, has been isolated from ovaries of pregnant animals in many species Accepted July 15, 1996 . Received April 16, 1996 . 'This work was supported by NSC grants 82-0412-B-010-043 and 83-0412-8-010-012. 2 Correspondence: Dr. Jiuan-Jiuan Hwang, Institute of Physiology, National Yang-Ming University, 155 Li-Nong St., Sec. 2, Taipei 112, Taiwan. FAX: 88628264049; e-mail: jiuanh@ym.edu.tw including rats [1], pigs [2] , and humans [3] . In rats, relaxin of high purity has been shown to play important roles in female reproductive functions [4] such as promotion of uterine growth [5] , inhibition of uterine contractility [6, 7] , softening of the uterine cervix [8] [9] [10] , lengthening of the interpubic ligament [11] , and promotion of mammary development [12] [13] [14] . These effects of relaxin are believed to contribute to the growth and safety of fetuses during pregnancy, the facilitation of birth processes, and the survival and growth of neonates [10, 12, [15] [16] [17] . The underlying mechanism(s) whereby relaxin exhibits its biological functions may be in part through its effect on the connective tissue remodeling of its target tissues, such as cervix [18. 19] and mammary apparatus [12, 13] .
In the nonpregnant rat, an intraovarian effect of relaxin has been suggested. First, relaxin immunoactivity and relaxin mRNA were shown to be present in the ovary of nonpregnant rats, while relaxin immunoactivity was undetectable in the peripheral blood [20, 21] . Second, Too and coworkers demonstrated that porcine relaxin increases the secreted activities of plasminogen activator, collagenase (type I), and proteoglycanase from cultured granulosa cells of gonadotropin-primed immature rats [22, 23] . These proteinases, involved in extracellular matrix remodeling, have been shown to play important roles in ovulation in rats [24] [25] [26] [27] [28] [29] . Finally, in a recent study human relaxin induced a small number of ovulations in the in vitro-perfused rat ovary [30] . In spite of this evidence, the physiological role of relaxin within the ovary in rats remains unclear. The present study had two objectives. The first was to determine the influence of relaxin on ovulation in rats by neutralizing endogenous relaxin with a monoclonal antibody specific for rat relaxin. The second was to investigate a possible mechanism for the effect of relaxin on ovulation. Since gelatinases belong to a class of proteolytic enzymes, named metalloproteinases, that are responsible for extracellular matrix remodeling [31] [32] [33] , the effect of relaxin on the secretion of gelatinases from cultured rat ovarian granulosa and theca-interstitial cells was determined.
MATERIALS AND METHODS

Materials
Porcine relaxin and monoclonal antibody against rat relaxin were generously provided by Dr. O.D. Sherwood (University of Illinois, Urbana-Champaign, IL). Most chemicals were purchased from Sigma Chemical Co. (St. Louis, MO); sources for others are identified individually below.
Animals
Immature Sprague-Dawley-derived rats were obtained from the Animal Center at National Yang-Ming University (Taipei, Taiwan). Rats were maintained under controlled temperature (20-23C) and light conditions (14L: 10OD) with free access to water and food (Lab Diet; PMI Feeds, Inc., St. Louis, MO).
Experiment 1: Influence of Relaxin on Ovulation In Vivo
This experiment was conducted in two stages. The aim in the first stage was to determine the effect of a monoclonal antibody against rat relaxin (MCAR) on ovulation in rats. The aim in the second stage was to investigate whether porcine relaxin could reverse the effect of MCAR on ovulation. This MCAR was previously designated MCA1 [11] . MCAR was previously shown by ELISA to be highly specific for rat relaxin but not for structurally similar molecules such as porcine relaxin, rat insulin, and rat insulin-like growth factor I and II [11] . Also, MCAR was shown to neutralize rat relaxin's biological activity in a mouse interpubic ligament bioassay [11] and to neutralize endogenous relaxin's bioactivities in pregnant rats [9, 10, [12] [13] [14] 16] .
In the first stage, three separate sets of experiments were conducted on the basis of workload and time constraints. The first set of experiments included PBS controls and rats treated with 0.025 and 0.25 Rg MCAR per ovary (n = 5, 4, and 5, respectively). The second set of experiments included PBS controls and rats treated with 0.25 and 2.5 Rig MCAR per ovary (n = 8, 6, and 6, respectively). The third set of experiments included PBS controls and rats treated with 2.5 jAg MCAF per ovary (n = 6 per group). MCAF, a monoclonal antibody specific for fluorescein (Boehringer Mannheim, Mannheim, Germany), served as the monoclonal antibody control. MCAF is the same isotype as MCAR (IgGI). In this stage of the experiment, rats at 25-26 days of age were injected s.c. with 10 IU eCG to induce follicle development. At 51 to 52 h later, animals were anesthetized using ether or fluothane (ICI Pharmaceuticals, Macclesfield Cheshire, England) and laparotomized for intraovarian bursal injection using a 30-gauge needle. Rats were each injected in both ovaries with 50 l of PBS vehicle, MCAR, or MCAF The injection was assured by swelling of the bursa. Rats were then sutured and injected i.p. with 15 IU hCG to induce ovulation. After another 26 h, the animals were killed under light ether anesthesia by cervical dislocation. Ovaries together with oviducts were removed and cleaned. Oviducts were then separated from ovaries, placed on glass slides, and examined under an inverted microscope to determine the number of ovulated oocytes. Percentage inhibition of ovulation was defined as [the difference between (the ovulation number for an individual rat) and (the mean ovulation number for the PBS control group)] divided by (the mean ovulation number for the PBS control group) x 100%. In this in vivo study, antibody was injected into both ovaries instead of a unilateral ovary because our preliminary experiment showed that the number of ovulated oocytes may vary significantly between the two ovaries of the same rat. Also, antibody was injected through the intraovarian bursa instead of the systemic circulation for two reasons. The first was to restrict antibody action mainly to the ovary. The other was to prevent low efficiency of antibody action in the ovary by the loss of antibody through peripheral clearance and the possibility of a low penetration rate of antibody through blood vessels and into the ovarian tissue.
In the second stage, most procedures were the same as in the first stage except that after intraovarian bursa injection of PBS or MCAR (2.5 ixg/ovary), rats were given s.c. 0.2 ml of 1% benzopurpurin 4B (an azo dye repository vehicle) [34] or 5 jag porcine relaxin in 1% benzopurpurin 4B. This stage included PBS controls, MCAR-treated rats, and MCAR plus porcine relaxin-treated rats (n = 4, 6, and 5, respectively). Porcine relaxin was used as an agonist for rat relaxin, while MCAR could be regarded as an antagonist since MCAR had been shown to be highly specific for rat relaxin but not for porcine relaxin [11] .
Experiment 2: Effects of Relaxin on Gelatinase Secretion from Ovarian Cells In Vitro
Isolation and culture of granulosa cells. Rats at 25-27 days of age were injected s.c. with 10 IU of eCG. Animals were killed 48 h later under light ether anesthesia by cervical dislocation. The purposes of using eCG-primed immature rats, instead of eCG plus hCG-treated immature rats as in the in vivo experiment, were to obtain granulosa cells from preovulatory and antral follicles and to avoid possible contamination with luteal cells in the isolated cell preparation. Ovaries were excised under aseptic condition and placed in sterile Dulbecco's modified Eagle medium (DMEM)/F-12 (1:1) containing 20 mM Hepes, 0.1% fatty acid-free BSA, 100 U/ml penicillin, and 100 jag/ml streptomycin. Granulosa cells were harvested as previously described [23] with slight modifications. In brief, large-and medium-sized follicles were punctured with a 26-gauge needle to release granulosa cells. The harvested cells were pelleted and resuspended in growth medium (DMEM/F-12 containing 10% fetal bovine serum, 2 ixg/ml bovine insulin, 100 U/ml penicillin, and 100 xg/ml streptomycin). Cell viability was greater than 90% as determined by the trypan blue dye exclusion method. Granulosa cells were plated in 24-well plates (Falcon Labware, Lincoln Park, NJ) at approximately 5 105 viable cells per well and were incubated at 37C, 5% CO 2 :95% air for two days. Cultured cells were then washed and incubated in 500 ,ul of serum-free medium (DMEM/F-12 containing 0.1% lactalbumin hydrolysate, 100 U/ml penicillin, and 100 ,ug/ml streptomycin) overnight prior to the beginning of treatment. Morphologically the cultured granulosa cells appeared nearly round (or polygonal) in shape, not like fibroblasts, throughout our culture conditions.
Isolation and culture of theca-interstitial cells. The residual ovarian tissues after isolation of granulosa cells were further processed to obtain theca-interstitial cells as previously described [35] with slight modifications. In brief, the residual tissues were cut into small pieces, washed, and subjected to two-step enzyme digestion. Tissues were first digested in DMEM/F-12 containing 1 mg/ml collagenase and 0.5 ag/ml DNase at 37 0 C for about 30 min to remove the adhering granulosa cells. The remaining tissues were washed and then further digested in DMEM/F-12 containing 4 mg/ml collagenase and 0.5 jag/ml DNase for another 30-40 min to obtain theca-interstitial cells. The cells were pelleted and resuspended in growth medium. Cell viability was greater than 95%. Theca-interstitial cells were first plated at approximately 1 x 106 cells per well in Falcon 6-well plates to obtain more cells for study. When the culture reached confluence at 2-3 days after plating, cells were dissociated with 0.5% trypsin-0.02% EDTA solution and plated at about 5 x 105 viable cells per well in 24-well plates. Cultures were incubated at 37C in 5% CO 2 :95% air for 1 day, and then washed and incubated in 500 R1l of serum-free medium overnight prior to the beginning of treatment. Liu and Hsueh had demonstrated that in response to hCG stimulation, this theca-interstitial cell preparation increased in secretion of androgen, while the levels of estrogen and progesterone did not change significantly in the presence or absence of androgen [35] . Also, our study showed that the morphology of the majority of cultured theca-interstitial cells showed a fibroblastic appearance throughout our culture conditions. Thus, we believe that the majority of the cells were theca-interstitial cells, although we cannot exclude the possibility of contamination of some other types of cells.
Hormonal treatment. Dose-and time-dependent effects of relaxin on the secretion of gelatinases from cultured rat ovarian cells were determined. To ascertain the dose-dependent effect, ovarian cells were incubated in the absence or presence of porcine relaxin in 500 i1l of serum-free medium for 24 h. Relaxin was given three times a day at 4-h intervals, each time at a dose of 0.5, 5, or 10 g in a small volume of 5 . 1 l. The final concentrations of relaxin were expressed as 1, 10, and 20 Ipg/ml. This treatment regimen was chosen on the basis of previous preliminary work of Too and coworkers [23] as well as our preliminary data showing that multiple relaxin treatment has a better stimulatory effect than single treatment for a 24-h incubation period on secreted plasminogen activator, collagenase, and gelatinase activities. In every experiment, each treatment group was done in triplicate. To determine the time-dependent effect, ovarian cells were incubated in the absence or presence of 10 tig/ml porcine relaxin for 6, 12, or 24 h. Samples of medium were then collected, cleared by centrifugation, and stored at -20 0 C until the performance of gelatin zymography. Cell numbers were determined using a hemacytometer.
Zymography analysis. Gelatin zymography was performed as previously described [36, 37] with slight modifications. In brief, samples of medium were electrophoresed on a 7.5% SDS-polyacrylamide gel containing 0.1% gelatin from porcine skin. The volume of each medium sample analyzed was normalized on the basis of cell number. Electrophoresis was run in 192 mM glycine, 25 mM Tris (pH 8.0), and 0.1% SDS at 15 mA/gel during stacking and at 20 mA/gel during separation. After electrophoresis, gels were washed in 2.5% Triton X-100 for about 1 h with a change of solution and then in reaction buffer (50 mM Tris-HC1, pH 8.0, containing 5 mM CaC1 2 , 0.02% NaN 3 ) for 15-20 min. Gels were incubated in reaction buffer at 37°C for 16-20 h, then stained with 0.25% Coomassie brilliant blue R-250 in 10% acetic acid-30% methanol, and destained in the same solution without dye. Quantification of gelatinases was achieved by computerized image analysis using a two-dimensional laser scanning densitometer (Molecular Dynamics, Sunnyvale, CA). To further characterize these gelatinases, gels after electrophoresis and Triton washing were incubated in reaction buffer containing metalloproteinase inhibitor (10 mM EDTA or 5 mM 1,10-phenanthroline) or serine/cysteine proteinase inhibitor (1 mM phenylmethylsulfonyl fluoride or 1 mM benzamidine) [38] . Gels were then stained and destained as described above.
Immunoblot analysis. Immunoblotting was conducted to determine whether relaxin stimulates the secretion of a type IV collagenase from cultured granulosa and theca-interstitial cells; a monoclonal antibody specific for human 72-kDa type IV collagenase was used. Samples of conditioned medium were concentrated using a Centricon 10 microconcentrator (Amicon, Denvers, MA) prior to electrophoresis. Immunoblotting was conducted using the Protoblot II AP 
Statistics
Data were examined using analysis of variance and Duncan's Multiple Range test at a significance level of 0.05. Student's t-test was used instead when there were only two treatment groups.
RESULTS
Influence of Relaxin on Ovulation In Vivo
Intraovarian bursal administration of monoclonal antibodies specific for rat relaxin (MCAR), 0.25 and 2.5 pig/ ovary, suppressed gonadotropin-induced ovulation in rats compared to the respective PBS controls (p < 0.05) ( Table  1 ). There was no significant difference in the number of ovulations between PBS and MCAF controls (Table 1) . Furthermore, exogenous porcine relaxin when given immediately after MCAR treatment significantly reversed the inhibitory effect of MCAR on gonadotropin-induced ovulation (p < 0.05) (Fig. 1) .
Effects of Relaxin on Gelatinase Secretion from Granulosa Cells In Vitro
Porcine relaxin, I and 10 g/ml, dose-dependently increased the secretion of two major gelatinases of about 92 and 63 kDa from cultured rat ovarian granulosa cells, whereas treatment with 20 iug/ml relaxin had an effect similar to that of 10 !ag/ml relaxin (Fig. 2) . The activity of 63-kDa gelatinase was stronger than that of 92-kDa gelatinase. Also, relaxin caused time-dependent increases in the secretion of both gelatinases within 24 h of treatment (Fig.  3) . The activities of 92-kDa gelatinase in conditioned media from controls and from rats treated with relaxin for 6 h were too weak to be properly quantified. Also, relaxin did not appear to influence the cell number for granulosa cells in this 24-h culture condition (data not shown).
Effects of Relaxin on Gelatinase Secretion from ThecaInterstitial Cells In Vitro
In contrast to the effect on granulosa cells, porcine relaxin induced the secretion of two different major gelatinases, about 76 and 71 kDa, from cultured rat ovarian theca-interstitial cells in a dose-dependent manner at doses of 1 and 10 txg/ml (Fig. 4) . Treatment with 20 g/ml relaxin produced an effect similar to that of 10 Rg/m relaxin (Fig.  4) . The activities of both gelatinases in conditioned media from controls were too weak to be properly quantified. Also, relaxin time-dependently induced the secretion of both gelatinases within 24 h of treatment (Fig. 5) . The cultured theca-interstitial cells also constitutively secreted gelatinases of about 66 and 63 kDa (Fig. 4A) , which appear not to be regulated by relaxin in the condition tested. Also, relaxin did not appear to influence the cell number for theca-interstitial cells in this 24-h culture condition (data not shown). ylmethylsulfonyl fluoride and mM benzam idine (Fig. 6 , relaxin increased the secretion of ovulation-associated enzyme activities, plasminogen activator, collagenase (type I), and proteoglycanase from cultured granulosa cells of gonadotropin-primed immature rats [22, 23] . Finally, a recent left panel). Furthermore, the immunoblot study using monoclonal antibody against human 72-kDa type IV collagenase demonstrated that relaxin stimulated the secretion of a 72-kDa type IV collagenase-like substance from cultured theca-interstitial cells but not from granulosa cells (Fig. 7) .
Characterization of Gelatinases
DISCUSSION
Research interest in relaxin's biological functions in female reproduction has been mainly focused on pregnancy in the species studied. However, several lines of evidence indicate that relaxin may exert an intraovarian effect on ovulation. First, several studies demonstrated that relaxin was produced in the ovary of nonpregnant animals in species such as rats [20, 21] , pigs [39] [40] [41] , hamsters [42] , and humans [43, 44] . Also, it was shown that LH stimulated the secretion of relaxin from cultured porcine preovulatory granulosa cells [45] and that porcine thecal cells were able to secrete relaxin, which was increased before ovulation [46] . Second, Too and coworkers demonstrated that porcine study showed that human relaxin induced a small number of ovulations in the in vitro-perfused rat ovary [30] .
In the present in vivo study, we demonstrated that intraovarian bursal injection of monoclonal antibodies specific for rat relaxin (MCAR) partially suppressed gonadotropin-induced ovulation in rats; moreover, this inhibitory effect of MCAR was reversed by concomitant administration of porcine relaxin. This indicates that endogenous relaxin may play a physiological role in the ovulatory process in rats. This concept is consistent with the recent work by Brannstrom and MacLenann [30] showing that exogenous human recombinant gene-2 relaxin (10 ptg/ml) induced ovulations in in vitro-perfused ovaries from eCG-primed immature rats and that its effect was comparable to that of 100 ng/ml ovine LH (2.4 0.2 and 3.0 + 0.8 oocytes per ovary, respectively). In our in vivo study, a PBS vehicle control group was included in each individual experiment in order to maintain a fair comparison among experimental groups. The variability in the mean numbers of ovulated oocytes in PBS controls among different sets of in vivo experiments could be attributable to the variability of experiments conducted at different times and on different batches of animals; that is, rats might exhibit different degrees of responses to eCG and hCG treatment or unknown environmental factor(s) may be involved. Nevertheless, we do wish to emphasize that the suppressive effect of MCAR on gonadotropin-induced ovulation was reproducible in our work (see Table 1 and Fig. 1) . Furthermore, we showed that exogenous porcine relaxin could reverse the effect of MCAR. In this experimental design, MCAR and porcine relaxin could be considered as the antagonist and agonist of endogenous rat relaxin, respectively, because MCAR is highly specific for rat relaxin but not for porcine relaxin.
There are at least two likely reasons why MCAR did not completely suppress gonadotropin-induced ovulation in rats. First, it may be that the MCAR administration regimen was incapable of complete neutralization of endogenous relaxin. Second, relaxin is most likely not the only factor involved in the ovulatory process. Several factors, including estrogen, prostaglandins, GnRH, and interleukin, in addition to gonadotropins, are believed to be involved in ovulation [47] [48] [49] [50] . Furthermore, whether relaxin is one of several ovarian factors that mediate gonadotropin action on ovulation in rats, or whether relaxin acts in a gonadotropinindependent manner, remains to be studied. However, the present investigation showed that administration of MCAR partially suppressed gonadotropin-induced ovulation in rats, suggesting the possibility that gonadotropin may stimulate the release of relaxin in nonpregnant rats. This suggestion is indirectly supported by the work of Loeken and coworkers [45] , who showed that LH stimulated relaxin release from cultured porcine preovulatory granulosa cells.
The involvement of extracellular matrix remodeling in ovulation has been previously postulated [24-29, 48, 49] . It is known that ovarian follicles are basically composed of granulosa cell layer(s), a basement membrane, theca cell layer(s), and other interstitial cells embedded in ovarian stromal connective tissue. Although both the stromal connective tissue and the basement membrane consist mainly of collagens and proteoglycans, there are distribution differences in the types of these components [51, 52] . For instance, interstitial (type I and III) collagens are localized mainly in the stromal connective tissue, while type IV collagen is in the basement membrane.
Previous studies and the present in vitro experiments provide a possible mechanism that contributes at least partly to relaxin's effect on ovulation. Too and coworkers showed that porcine relaxin stimulated an increase in collagenase activity [23] ; this most likely represents the interstitial collagenase activity, since type I collagen instead of type IV collagen was used as the substrate for collagenase assay. The present in vitro study demonstrates that porcine relaxin stimulated the secretion of 92-kDa and 63-kDa gelatinases from cultured rat granulosa cells, while their identities await further characterization. Furthermore, this study demonstrates for the first time that porcine relaxin exhibits a biological function in rat theca-interstitial cells to induce the secretion of two major gelatinases of 76 kDa and 71 kDa. It is likely that the 71-kDa gelatinase may be a type IV collagenase as indicated by immunoblot analysis using monoclonal antibody against human 72-kDa type IV collagenase (Fig. 7) . In addition, the estimated molecular sizes of gelatinases (92 and 63 kDa from granulosa cells; 76, 71, 66, and 63 kDa from theca-interstitial cells) were similar to those of two other studies. Curry and coworkers demonstrated the presence of 78-, 72-, 66-, and 62-kDa gelatinases in extracts of preovulatory ovaries from gonadotropinprimed immature rats [29] ; Hurwitz and coworkers showed the presence of 92-and 72-kDa gelatinases in conditioned media of cultured whole ovarian dispersates from immature rats [50] . Together, our study as well as the investigations of Too and coworkers suggest that relaxin may be important for structural remodeling in the rat ovary.
Though the range of relaxin doses (at the nM to M level) used in our ovarian cell culture work appears high in a general sense, it is similar to that used in the work of Too and colleagues (porcine relaxin at 0.4-10 ,ag/ml) [22, 23] and to that used in Brannstrom and MacLennan's work (human relaxin at 10 txg/ml) [30] . Several factors may contribute to the relaxin doses used in the study. First, it is known that relaxin is produced in the ovary of nonpregnant rats and that relaxin immunoactivity levels are low in the peripheral blood [20, 21] . It is possible that the distribution of relaxin within the ovary is heterogeneous. This may result in higher local concentrations of relaxin in certain areas within the ovary. In addition, the local relaxin concentration may be high in order to overcome the limited number of relaxin receptors in ovarian cells. Second, it is possible that the sensitivity of relaxin bioactivity might decrease with the use of heterologous relaxin (porcine relaxin or human re-laxin) rather than homologous relaxin (rat relaxin) in the studies in which we and others have used rats as experimental animals. Also, we cannot exclude the possibilities that cell responsiveness to relaxin may be disturbed in the in vitro culture system and that relaxin may exhibit a pharmacological effect on the secretion of gelatinases from cultured ovarian cells in this in vitro study.
In conclusion, the present study supports the idea that relaxin may play an autocrine/paracrine role involved in ovarian connective tissue remodeling in rats. Moreover, this intraovarian effect of relaxin may be important in follicular development and transformation as well as in ovulation.
